NCT01134770
Prenatal Exposure Effects Psychophysiology Study
Enrolling by Invitation
Not specifiedAges 18–45ObservationalUniversity of North Carolina, Chapel HillInvestigator-initiated
~150 participants
Updated 2026-02-04 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Determine the effect of prenatal cocaine exposure on the neonatal brain. ventricular volumes
Measured over 2 to 4 weeks of age
Conditions
Where it's being run
1 sites across 1 statesNorth Carolina1
Study leadership
- Karen Grewen, PhD · PRINCIPAL_INVESTIGATOR · University of North Carolina, Chapel Hill
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
During pregnancy, mother has used any of the following:
cocaine
marijuana and/or alcohol but not cocaine
nicotine (smoked cigarettes)
no drugs during pregnancy
Mother is pregnant or no more than 4 weeks postpartum
Exclusion
Mother has cardiovascular disease
Delivery before 36 weeks or later than 42 weeks gestation
Birth weight less than 5.5 lbs
Baby was a multiple birth
What this trial measures
- Determine the effect of prenatal cocaine exposure on the neonatal brain. ventricular volumes2 to 4 weeks of age